We’re leveraging cutting-edge research out of MIT and published in NATURE to bring a medical wearable tech device that has demonstrated in clinical trials to remove the plaque in the brain that causes Alzheimer’s. Our Founder Kim Lavine has spent over 3 and a half years in research and development of stroboscopic technology, adopted by superstar athletes like NBA MVP Steph Curry, as demonstrated in interviews on ESPN and in GQ, Business Insider and more. This technology is supported by decades of clinical research by NASA and major universities. This is a first-to-market opportunity and our major competitor is Cognito Therapeutics, a company founded by the MIT researchers with $10M in funding from a Boston VC. This company is yet to develop the appliance to deliver the stroboscopic therapy and are using instead invasive flashing lights. Our design is complete and our production successfully sourced with potential retail distribution to desperate sufferers in 2019.
There are 30 million Alzheimer’s sufferers globally and that number will explode to 160 million by 2050. Current medications approved by the FDA only treat the symptoms, not the causes of the disease. Our technology has been shown in clinical trials to reduce the plaque in the brain that causes Alzheimer’s through a safe, easy to use, non-invasive therapy, preventing and potentially reversing the effects of memory loss.
What I Will Do With $5,000
We will use the $5,000 to convert our provisional patent application (PPA) to a non-provisional patent to be filed with the USPTO. We are working with one of the most successful intellectual property attorneys in Silicon Valley, who feels confident we will be granted both design and utility patent protection.